0

Select Language

BHOOMI MARKETING CO.

Paclitaxel Injection Ip

Paclitaxel Injection Ip

Paclitaxel Injection Ip

Product Description

COMPOSITION:

Each ml contains:
	Paclitaxel IP 6 mg
	Polyoxyl 35 Castor Oil USNF 527 mg
	Dehydrated IP 49.7% v/v

INDICATIONS :

	Paclitaxel Injection (INTAXEL) is indicated as first-line and subsequent therapy for the treatment of advanced carcinoma of the ovary. As first-line therapy, Paclitaxel Injection is indicated in combination with cisplatin.
	Paclitaxel Injection (INTAXEL) is indicated for the adjuvant treatment of node-positive breast cancer administered sequentially to standard doxorubicin-containing combination chemotherapy.
	Paclitaxel Injection (INTAXEL) is indicated for the treatment of breast cancer after failure of combination chemotherapy for metastatic disease or relapse within 6 months of adjuvant chemotherapy. Prior therapy should have included an anthracycline unless clinically contraindicated.
	Paclitaxel Injection (INTAXEL) in combination with cisplatin, is indicated for the first-line treatment of non-small cell lung cancer in patients who are not candidates for potentially curative surgery and/or radiation therapy.
	Paclitaxel Injection (INTAXEL) is indicated for the second-line treatment of AIDS- related Kaposi's sarcoma.

PRESENTATION: :

30 mg/5ml, 100 mg/17ml and 260 mg/43.4 ml vials individually packaged in a carton.

Related Products

Cytarine (Cytarabine)

Cytarine (Cytarabine)

Cladrim (Cladribine)

Cladrim (Cladribine)

Contact Us

5, SUNDERVAN SOCIETY, NEAR NAVGUJARAT COLLEGE, ASHRAM ROAD, USMANPURA, Ahmedabad, Gujarat, 380014, India